Technology evaluation: gemtuzumab ozogamicin, Celltech Group.
Year: 2000
Type: article
Source: PubMed
Author: I Niculescu-Duvaz
Institution: Institute of Cancer Research
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W56569517
